| CASE REPORT |
|
| Year : 2017 | Volume
: 11
| Issue : 2 | Page : 232-235 |
|
|
A case report of suspected malignant hyperthermia where patient survived the episode
Asif Iqbal, Shoaib Badoo, Ruqsana Naqeeb
Department of Anaesthesiology and Critical Care, SMHS Hospital, GMC, Srinagar, Jammu and Kashmir, India
Correspondence Address:
Asif Iqbal
36, Ram Bagh Extension, Near Noorani Masjid, Srinagar - 190 015, Jammu and Kashmir
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1658-354X.203057
|
|
|
Malignant hyperthermia is rare inherited disorder in our part of the world; there are only few cases reported in literature in India who were suspected of having this condition. The overall incidence of malignant hyperthermia during general anesthesia is estimated to range from 1: 5000 to 1: 50,000–100,000 and mortality rate is estimated to be <5% in the presence of standard care. In India, there is no center where in vitro halothane caffeine contraction test is performed to confirm diagnosis in suspected cases. Second, dantrolene drug of choice for this condition is not freely available in market in India and is stored only in some hospitals in few major cities. Among the cases reported of suspected of malignant hyperthermia in India almost 50% have survived the condition despite nonavailability of dantrolene emphasizing role of early detection and aggressive management in these cases.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
